Development of a capillary electrophoresis assay for the determination of carvedilol enantiomers in serum using cyclodextrins.

J Pharm Biomed Anal

Division of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada.

Published: February 2001

A capillary electrophoresis method using cyclodextrins as the chiral selectors was developed for the determination of carvedilol enantiomers in serum. Several types of cyclodextrins were evaluated. The effect of cyclodextrin concentration on enantiomer resolution was investigated. Best results were obtained using 10 mM hydroxypropyl-beta-cyclodextrin in the run buffer. The effect of voltage on efficiency was assessed. Other electrophoretic conditions were optimized. The method was validated for carvedilol enantiomers in serum. Linearity of detection was assessed over the concentration range of 50-4000 ng/ml of each enantiomer in serum. Intra- and inter-assay variability obtained were under 8% for both enantiomers.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0731-7085(00)00468-4DOI Listing

Publication Analysis

Top Keywords

carvedilol enantiomers
12
enantiomers serum
12
capillary electrophoresis
8
determination carvedilol
8
development capillary
4
electrophoresis assay
4
assay determination
4
enantiomers
4
serum
4
serum cyclodextrins
4

Similar Publications

Aims: A population-based pharmacokinetic (PK) modeling approach (PopPK) was used to investigate the impact of Roux-en-Y gastric bypass (RYGB) on the PK of (R)- and (S)-carvedilol. We aimed to optimize carvedilol dosing for these patients utilizing a pharmacokinetic/pharmacodynamic (PK/PD) link model.

Methods: PopPK models were developed utilizing data from 52 subjects, including nonobese, obese, and post- RYGB patients who received rac- carvedilol orally.

View Article and Find Full Text PDF
Article Synopsis
  • Hypercontractility and arrhythmia are significant issues in hypertrophic cardiomyopathy (HCM), and while beta-blockers are the standard treatment, they can lead to unwanted side effects like fatigue and lowered cardiac output.
  • Researchers screened 21 different beta-blockers and found that carvedilol, which is not commonly used for HCM, effectively reduces heart muscle contractility and arrhythmia through inhibition of the ryanodine receptor type 2 (RyR2) without dropping heart rate.
  • The study suggests that carvedilol’s unique properties, particularly its R-enantiomer, may offer a promising alternative treatment for HCM patients, combining antiarrhythmic effects and reduced contractility without compromising overall heart performance.
View Article and Find Full Text PDF

Mitigation of Nitrogen Mustard-Induced Skin Injury by the -Blocker Carvedilol and Its Enantiomers.

J Pharmacol Exp Ther

January 2024

Department of Biotechnology and Pharmaceutical Sciences, College of Pharmacy, Western University of Health Sciences, Pomona, California

The chemical warfare agent sulfur mustard and its structural analog nitrogen mustard (NM) cause severe vesicating skin injuries. The pathologic mechanisms for the skin injury following mustard exposure are poorly understood; therefore, no effective countermeasure is available. Previous reports demonstrated the protective activity of carvedilol, a US Food and Drug Administration (FDA)-approved -blocker, against UV radiation-induced skin damage.

View Article and Find Full Text PDF

Carvedilol, a highly protein-bound beta-blocker, is used in therapy as a racemic mixture of its two enantiomers that exhibit different pharmacological activity. The aim of this study was to evaluate the stereoselective nature of its binding to the two major plasma proteins: albumin and alpha-1-acid glycoprotein. The determination of the plasma protein-binding degree for carvedilol and its enantiomers was achieved using ultrafiltration for the separation of the free fraction, followed by LC-MS/MS quantification, using two different developed and validated methods in terms of stationary phase: achiral C18 type and chiral ovomucoid type.

View Article and Find Full Text PDF

Enantioseparation of five β-adrenergic blockers was studied using two mobile phases on a cellulose tris(3-chloro-4-methylphenylcarbamate) (Lux-Cellulose-2) chiral column in normal phase mode. The first mobile phase composed of n-hexane: ethanol: diethylamine 60: 40: 0.1 by volume has successfully resolved the chromatographic peaks of three pairs of β-adrenergic blockers namely, bisoprolol, carvedilol and atenolol.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!